Additional European Equity News

CRH (CRH LN) - FY21 (USD): Revenue 31bln (prev. 27.6bln). Co. expects underlying demand and pricing to remain favorable this year. (Newswires) 

Darktrace (DARK LN): H1 (USD): Net profit 5.9mln (prev. -48.4mln Y/Y). Co. upgrades prior guidance for FY22. Cybersprint acquisition will impact guidance. (Newswires)

Entain (ENT LN) – FY21 (GBP): Revenue 3.83bln (exp. 3.84bln), EBITDA 881mln (exp. 874mln). Not proposing a FY21 dividend. Upgrading expectations for BetMGM new revenue from operations of over USD 1.3bln in 2022, expects positive EBITDA in 2023. (Newswires)

Galliford Try (GFRD LN)  - H1 (GBP): revenue 594mln (prev. 542mln Y/Y). Pretax +7.1mln (-2.6mln). (Newswires)

ITV (ITV LN) – FY21 (GBP): Total Revenue 3.45bln (exp. 3.37bln), Operating Profit 519mln (exp. 550mln), adj. EPS GBP 0.153 (exp. 0.149). (Newswires)

LSE (LSEG LN) - FY21 (GBP) - Adj. profit from cont. ops at 1.823bln, +44.6% Y/Y. Total income +0.8% Y/Y. Dividend 0.95/shr (exp. 0.88/shr). Expects adj. operating expenses to grow at low single digit rate in 2022 and 2023. (Newswires)

Meggit (MGGT LN) - FY21 (GBP): Revenue 1.49bln (prev. 1.68bln Y/Y). EBITDA 291mln (prev. 296.9mln) (Newswires) 

Rentokil (RKT LN) - FY21 (GBP): Revenue 2.96bln (prev. 2.80bln). Operating profit 346mln (prev. 293.8mln). (Newswires)  

Sanofi (SAN FP) - Nirsevimab significantly protected infants against RSV disease in Phase 3 trial. (Sanofi)

SocGen (GLE FP) - Exposure to Russia limited at EUR 18.6bln (with Eur 15.4bln related to Rosbank unit). (Newswires)

Telecom Italia (TIT IM) – CEO says KKR’s proposal appears to target a spin-off of network and other assets, which is what they are planning to do internally to benefit shareholders. Expect to close the deal with Ardian on the Inwit stake in H1, following the clearance of anti-trust and golden power hurdles. (Newswires)

03 Mar 2022 - 07:41- EquitiesResearch Sheet- Source: Newsquawk